Related Experiment Video
Updated: Jun 2, 2026

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
Daxx-beta and Daxx-gamma, two novel splice variants of the transcriptional co-repressor Daxx
Nils Wethkamp1, Helmut Hanenberg, Sarah Funke
1Institute of Pathology, Heinrich Heine University, University Hospital, Medical Faculty, Düsseldorf, Germany.
Abstract:
Daxx is involved in transcriptional control and apoptosis. It comprises several domains, including a regulatory C terminus that is responsible for the interaction with numerous proteins such as p53, promyelocytic leukemia protein (PML), and Hsp27. Here, we describe the identification and characterization of two novel variants of Daxx termed Daxx-β and Daxx-γ, which are generated by alternative splicing. Alternative splicing results in a truncated regulatory C terminus in both proteins. As a consequence, Daxx-β and Daxx-γ show a markedly decreased affinity to PML, which in turn is associated with a different subnuclear localization of these proteins compared with Daxx. Although Daxx is localized mainly in PML-oncogenic domains (PODs) Daxx-β and Daxx-γ display a distinct distribution pattern. Furthermore, Daxx-β and Daxx-γ show a decreased affinity to p53 also due to the truncated C terminus. We provide evidence that the p53 recruitment into PODs is Daxx isoform-dependent. The decreased affinity of Daxx-β/-γ to p53 and PML results in a diffuse localization of p53 throughout the nucleus. In contrast to Daxx, Daxx-β and Daxx-γ are unable to repress p53-mediated transcription. Therefore, alternative splicing of Daxx might indicate an additional level in the cellular apoptosis network.
Insights
Novel Daxx variants, Daxx-β and Daxx-γ, generated by alternative splicing, exhibit altered interactions with p53 and PML. These variants impact p53 localization and fail to repress transcription, suggesting a new layer in apoptosis regulation.
Area of Science:
- Molecular Biology
- Cell Biology
- Genetics
Background:
- Daxx protein regulates transcription and apoptosis, interacting with key proteins like p53 and PML via its C terminus.
- Alternative splicing is a known mechanism for generating protein diversity.
Purpose of the Study:
- To identify and characterize novel Daxx variants generated through alternative splicing.
- To investigate the functional consequences of these variants on protein interactions and cellular processes.
Main Methods:
- Identification and characterization of Daxx variants.
- Analysis of protein-protein interactions (Daxx, p53, PML).
- Subcellular localization studies using microscopy.
- Assessment of transcriptional repression activity.
Main Results:
- Two novel Daxx variants, Daxx-β and Daxx-γ, were identified, arising from alternative splicing.
- Both variants possess a truncated C terminus, leading to reduced affinity for PML and p53.
- Daxx-β and Daxx-γ exhibit distinct subnuclear localization compared to wild-type Daxx, with p53 showing diffuse nuclear distribution.
- These variants are unable to repress p53-mediated transcription, unlike wild-type Daxx.
Conclusions:
- Alternative splicing of Daxx generates functional isoforms with altered protein-binding properties and cellular localization.
- Daxx variants modulate p53 interactions and transcriptional activity, indicating isoform-specific roles in apoptosis regulation.
- This suggests alternative splicing of Daxx represents a novel regulatory mechanism within the cellular apoptosis network.
Related Concept Videos
Exon Recombination
Exon shuffling follows “splice frame rules.” Each exon has three reading...
Master Transcription Regulators
Master Transcription Regulators
Co-activators and Co-repressors
Co-activators and Co-repressors
General Transcription Factors

